Search

Now showing items 1-10 of 18

Ageing and recurrent episodes of neuroinflammation promote progressive experimental autoimmune encephalomyelitis in Biozzi ABH mice

Peferoen, LAN; Breur, M; van de Berg, S; Peferoen-Baert, R; Boddeke, EHWGM; van der Valk, P; Pryce, G; van Noort, JM; Baker, D; Amor, S (2016-10)

Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis

Al-Izki, S; Pryce, G; Hankey, DJR; Lidster, K; von Kutzleben, SM; Browne, L; Clutterbuck, L; Posada, C; Chan, AWE; Amor, S;... (2014-01)

Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease

Ummenthum, K; Peferoen, LAN; Finardi, A; Baker, D; Pryce, G; Mantovani, A; Bsibsi, M; Bottazzi, B; Peferoen-Baert, R; van der Valk, P;... (2016-03)

Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis

Puentes, F; van der Star, BJ; Victor, M; Kipp, M; Beyer, C; Peferoen-Baert, R; Ummenthum, K; Pryce, G; Gerritsen, W; Huizinga, R;... (2013-09-22)

Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis.

Puentes, F; van der Star, BJ; Victor, M; Kipp, M; Beyer, C; Peferoen-Baert, R; Ummenthum, K; Pryce, G; Gerritsen, W; Huizinga, R;... (2013)

Autoimmunity to neuronal proteins occurs in several neurological syndromes, where cellular and humoral responses are directed to surface as well as intracellular antigens. Similar to myelin autoimmunity, pathogenic immune ...

Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis

Puentes, F; van der Star, BJ; Victor, M; Kipp, M; Beyer, C; Peferoen-Baert, R; Ummenthum, K; Pryce, G; Gerritsen, W; Huizinga, R;... (2013)

Two Years Later: Journals Are Not Yet Enforcing the ARRIVE Guidelines on Reporting Standards for Pre-Clinical Animal Studies

Baker, D; Lidster, K; Sottomayor, A; Amor, S (2014-01)

Search

Ageing and recurrent episodes of neuroinflammation promote progressive experimental autoimmune encephalomyelitis in Biozzi ABH mice

Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis

Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease

Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis

Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis.

Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis

Two Years Later: Journals Are Not Yet Enforcing the ARRIVE Guidelines on Reporting Standards for Pre-Clinical Animal Studies

CD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis - Targeting T or B cells?

Neurofilament light as an immune target for pathogenic antibodies.

Learning from other autoimmunities to understand targeting of B cells to control multiple sclerosis

Search

Filters

Ageing and recurrent episodes of neuroinflammation promote progressive experimental autoimmune encephalomyelitis in Biozzi ABH mice

Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis

Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease

Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis

Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis.

Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis

Two Years Later: Journals Are Not Yet Enforcing the ARRIVE Guidelines on Reporting Standards for Pre-Clinical Animal Studies

CD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis - Targeting T or B cells?

Neurofilament light as an immune target for pathogenic antibodies.

Learning from other autoimmunities to understand targeting of B cells to control multiple sclerosis